Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Asahi discloses anxiolytic/cognition-enhancing drugs

May 3, 1996

Teijin reports vitamin D3 derivatives for osteoporosis

May 3, 1996

Toray's MIP for treatment of ophthalmological disorders

May 3, 1996

EPC-K claimed for ophthalmic use

May 3, 1996

Hybridon reports oligonucleotide MDR inhibitors

May 3, 1996

Sankyo macrophage activators claimed as immunostimulants, antineoplastics

May 3, 1996

Antitumor nucleosides disclosed by Yamasa Shoyu

May 3, 1996

Fujisawa reports collagenase inhibitors

May 3, 1996

New immunosuppressants from Shionogi

May 3, 1996

Malaria vaccine lead reported by Johns Hopkins

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...